Samsung Pharm (001360) — Cash Flow Quality Index
Samsung Pharm (001360) has a Cash Flow Quality Index of -0.01x as of June 2025. Operating cash flow of ₩-804.23 Million is below net income of ₩63.57 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 001360 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Samsung Pharm Cash Flow Quality Index (2019–2019)
Historical Cash Flow Quality Index for Samsung Pharm across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Samsung Pharm total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Samsung Pharm (2019–2019)
Year-by-year earnings quality comparison for Samsung Pharm. For live market cap and the full company financial profile, see Samsung Pharm stock valuation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | -0.35x | ₩-2.43 Billion | ₩6.89 Billion | — |